A porcine hepatitis E virus antigenic epitope and its application
A technology for swine hepatitis E and virus antigen, which is applied in the directions of viral peptides, antiviral agents, and medical preparations containing active ingredients, etc., can solve the problems of not being able to specifically reflect the epidemic pattern of swine hepatitis E, and the specificity is not strong.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0040] Example 1 Porcine hepatitis E virus surface antigen
[0041] The computer software is used to screen the recognition epitopes from the corresponding proteins of the open reading frames ORF1, ORF2 and ORF3 of the whole genome of porcine hepatitis E virus. Epitope recognition is mainly based on the hydrophilicity, surface degree, flexibility of protein or polypeptide amino acid sequence, Chou-Fasman's helix, sheet and turn, Robson-Garnier's secondary structure and C- and N-terminus to predict Antigen comprehensive data (Antigenic Index, AI). Using existing software, such as: GCG (Madison, Wisconsin, USA) and DNAStar (Madison, Wisconsin, USA) to calculate AI and auxiliary recognition antigen regions from ORF1, ORF2 and ORF3 proteins of pig HEV. According to the amino acid sequences obtained from the known proteins of ORF1, ORF2 and ORF3 of porcine HEV, computer programs were used to estimate their antigenic regions (AI) (generally 10 to 15 amino acids).
[0042] After an...
Embodiment 2
[0107] Example 2 Screening of Porcine Hepatitis E Virus Epitopes
[0108] Firstly, the pig HEV total antibody ELISA kit produced by Beijing Wantai Industrial Biomedicine Co., Ltd. was used to identify the collected pig serum, and screened out pig HEV positive serum and negative serum.
[0109] The porcine HEV polypeptide obtained in Example 1 was identified by ELISA with porcine HEV positive serum and negative serum, and porcine HEV epitope antigen was screened out. The specific steps are as follows:
[0111] Take 10 μl of the peptide with a concentration of 10 mg / ml (dissolved 5 mg of the synthesized peptide in 0.5 ml of dimethyl sulfoxide (DMSO)) and mix it with 90 ul of PBS to obtain an antigen dilution solution with a solubility of 1 μg / μl. Then take 15 μl of the diluted antigen solution and mix with 5 ml of the coating solution to obtain a diluted antigen solubility of 3 μg / ml. Add antigen dilution to 100 μl / well on the microtiter plate, an...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com